Respiratory disorders are common in the Australian community. One common disorder is asthma, which affects around 10% of the population. Another common disorder is chronic obstructive pulmonary disease (COPD), which affects between 10-20% of people over the age of 40 – around 2.1 million Australians at any one time. Lung cancer is the fourth most commonly diagnosed cancer and the most common cause of cancer-related death in both men and women.
Other conditions that IBAS is actively involved in researching include fibrotic lung diseases, such as pulmonary fibrosis, mesothelioma and bronchiectasis.
All respiratory disorders have a range of negative health outcomes for those affected. Given how essential breathing is to everything we do, the specific symptoms of the condition can be both debilitating and frightening. The ongoing effects of a respiratory illness can lead to frequent hospitalisations and affects people’s ability to work and enjoy their lives.
Respiratory diseases burden people experiencing the disease as well as their family, friends and carers. In addition, respiratory disease places a financial burden on the Australian community. These costs include health and hospital costs as well as lost productivity.
Since the Institute was established in 2000, our team has led successful research in a number of key areas including:
IBAS also runs clinical trials that are sponsored by pharmaceutical companies – these trials can provide individuals with access to new treatments as well as benefitting society by advancing our knowledge of treatments.
To see current IBAS respiratory projects, click here.
As breathing and sleep disorders often overlap, our research into breathing and sleep disorders are interlinked. To find out more about our sleep research, click here.
More information on respiratory disorders can be found at the following websites:
If you have concerns about yours or someone else’s breathing, please either:
|
HEALTHY MALES AND FEMALES WANTED FOR SLEEP STUDY
Interested to participate in a study investigating the effect of fatigue on driving performance?
Interstitial lung disease (ILD) is a chronic lung condition that causes stiff lungs and restricts sufferers from taking a deep breath. Exercise in a gym, or swimming, walking or riding a bike, can help...
Sleep apnea is a condition where breathing is abnormal during sleep. There are two main forms of sleep apnea: obstructive and central. For obstructive sleep apnea, breathing is reduced because the airway...
IBAS SUCCESS IN 2022 AMRF RESEARCH GRANT SCHEME
Congratulations to the following IBAS staff members who have been successful in obtaining research funding from the Austin Medical Research Foundation (AMRF) for 2022.
DR MARNIE GRACO RECEIVES THE ROB PIERCE GRANT
Honouring a legacy: The prestigious 2021 Rob Pierce Grant in Aid is awarded to Dr Marnie Graco, a physiotherapist and implementation scientist from IBAS.
IBAS RESEARCHER IS AWARDED TSANZ PRIZE IN 2021
Dr Anna Ridgers, Respiratory and Sleep Physician and IBAS Associate Researcher, has been awarded best oral presentation at the TSANZ annual scientific meeting in the interventional pulmonology category.
DEPT OF RESPIRATORY & SLEEP MEDICINE AND IBAS WINNERS
DRSM and IBAS members were well-represented in the awards by the Thoracic Society of Australia and New Zealand (TSANZ) and the Australian and New Zealand Society of Respiratory Science (ANZSRS).
© 2022 Institute for Breathing and Sleep. All Rights Reserved. ABN 39 093 685 879
Powered by Helmut Design | Manage
